Carr v. Johnson & Johnson Consumer Inc.

CourtDistrict Court, E.D. New York
DecidedMay 17, 2023
Docket1:21-cv-06557
StatusUnknown

This text of Carr v. Johnson & Johnson Consumer Inc. (Carr v. Johnson & Johnson Consumer Inc.) is published on Counsel Stack Legal Research, covering District Court, E.D. New York primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Carr v. Johnson & Johnson Consumer Inc., (E.D.N.Y. 2023).

Opinion

UNITED STATES DISTRICT COURT EASTERN DISTRICT OF NEW YORK ------------------------------------x

TYESHAH CARR, on behalf of herself and all others similarly situated, MEMORANDUM & ORDER Plaintiff, 21-CV-6557(EK)(JRC)

-against-

JOHNSON & JOHNSON CONSUMER INC. and VOGUE INTERNATIONAL LLC,

Defendants.

------------------------------------x ERIC KOMITEE, United States District Judge: Plaintiff Tyeshah Carr brings this putative class action against Defendants Johnson & Johnson Consumer Inc. (“JJCI”) and Vogue International LLC (“Vogue”), alleging that their haircare products contained a dangerous chemical that caused her hair loss and various scalp injuries. She alleges claims for design defect, failure to warn, and negligence. Defendants now move to strike the class allegations in the complaint. Defendants have not yet answered or moved to dismiss, and Plaintiff has not yet sought to certify the proposed class. For the reasons set forth below, the motion to strike is denied without prejudice to renew. I. Background The following recitation is taken from the complaint. Vogue and JJCI develop, market, and distribute a line of shampoo and conditioner products under the brand name “OGX” (the “OGX Products”). Compl. ¶¶ 27–29, ECF No. 1. In February 2021, Carr alleges, she (and her daughter) “used OGX Products” as directed on the product label. Id. ¶¶ 13, 62, 64. (Despite the reference to “OGX Products,” plural, she identifies by name only one

product that they used — the “OGX Renewing and Argan Oil of Morocco” product. See id. ¶ 14.) After washing, Carr suffered “significant hair loss” and “hair thinning,” and her “once healthy” hair “became brittle” and “fell out in clumps.” Id. ¶¶ 15, 64–65. She further experienced “severe scalp irritation, redness, rashes, itching, and burning.” Id. ¶ 64. Carr’s daughter suffered “a similar injury, with significant hair loss.” Id. ¶ 65. After Carr stopped using the OGX Products, she no longer experienced any “new hair loss, hair thinning, or scalp irritation.” Id. ¶ 66. Similarly, her daughter’s “hair loss slowed” after she stopped using the products. Id.

The OGX Products in question contained “DMDM hydantoin,” a chemical compound that works as a preservative and releases formaldehyde. Id. ¶¶ 4, 14, 35–36. According to the complaint, medical and scientific studies over the last few decades have shown the “harmful effects” of formaldehyde and DMDM, linking the chemicals to reactions such as dermatitis, itchiness, and red rashes. Id. ¶¶ 4, 37–39. Carr alleges that Defendants have known about the harms associated with DMDM “for approximately a decade.” Id. ¶ 61. In August 2012, for example, JJCI committed to phasing “formaldehyde and other harmful ingredients” out of its adult personal care products by the end of 2015. Id. ¶¶ 5, 50.

JJCI’s own commitments, as well as DMDM-related litigation against an industry competitor and online consumer reviews of DMDM-containing products, also put Defendants on notice of DMDM’s effects. Id. ¶¶ 48–59. Defendants removed DMDM from their OGX Products in or around September 2021. Id. ¶¶ 9–10. Carr brings strict products-liability and negligence claims against Defendants on behalf of the following class: All residents of the United States who purchased OGX Products containing DMDM and suffered hair loss, thinning hair, or other injuries after using the product, who have retained Squitieri & Fearon, LLP as their counsel, and who have not separately filed a lawsuit against Defendants by the date of the class certification order. Id. ¶ 67. She alleges that the OGX Products caused an “unreasonably high rate of adverse dermatological and other reactions” due to DMDM — indeed, that “hundreds or thousands of other consumers” also suffered hair loss or other injuries from them. Id. ¶¶ 2, 92. And Carr alleges that Defendants could have used non-DMDM alternatives as preservatives or reduced the amount of DMDM in their products. Id. ¶ 91. She also alleges that Defendants failed to warn consumers about the risks posed by the OGX Products. Id. ¶¶ 96–105. II. Legal Standards A. Motions to Strike Class Allegations Under Rule 12(f), a court may, sua sponte or on a motion, “strike from a pleading” “any redundant, immaterial,

impertinent, or scandalous matter.” Fed. R. Civ. P. 12(f). Separately, Rule 23 calls for the court to determine “whether to certify the action as a class action” at “an early practicable time after a person sues . . . as a class representative.” Fed. R. Civ. P. 23(c)(1)(A). “Motions to strike under Rule 12(f) are rarely successful.” Greene v. Gerber Prod. Co., 262 F. Supp. 3d 38, 52 (E.D.N.Y. 2017).1 “A motion to strike class allegations under Rule 12(f) is even more disfavored because it requires a reviewing court to preemptively terminate the class aspects of litigation, solely on the basis of what is alleged in the

complaint, and before plaintiffs are permitted to complete the discovery to which they would otherwise be entitled on questions relevant to class certification.” Belfiore v. Procter & Gamble Co., 94 F. Supp. 3d 440, 447 (E.D.N.Y. 2015). For this reason,

1 Unless otherwise noted, when quoting judicial decisions this order accepts all alterations and omits all citations, footnotes, and internal quotation marks. “district courts in this Circuit have frequently found that a determination of whether Rule 23 requirements are met is more properly deferred to the class certification stage, when the court has before it a more complete factual record from which to make its determination.” Greene, 262 F. Supp. 3d at 53. In

other words, a motion to strike class claims is generally “considered premature if the issues raised are the same ones that would be decided in connection with determining the appropriateness of class certification under Rules 23(a) and 23(b).” Kassman v. KPMG LLP, 925 F. Supp. 2d 453, 464 (S.D.N.Y. 2013). Against that background, courts within the Second Circuit generally grant motions to strike class allegations in only two circumstances. First, a motion to strike may be appropriate for early resolution if it “addresses issues separate and apart from the issues that will be decided on a class certification.” Hidalgo v. Johnson & Johnson Consumer

Cos., Inc., 148 F. Supp. 3d 285, 292–93 (S.D.N.Y. 2015). This was the case in Rahman v. Smith & Wollensky, for example, where the basis for the Rule 23 motion to strike — exhaustion of absent members’ claims — was “an issue separate and apart from the issues . . . decided on a class certification motion.” See No. 06-CV-6198, 2008 WL 161230, at *3 (S.D.N.Y. Jan. 16, 2008) (Francis, M.J.). Second, a court may grant a motion to strike if the defendant can “demonstrate from the face of the complaint that it would be impossible to certify the alleged class regardless of the facts the plaintiffs may be able to obtain during discovery.” Reynolds v. Lifewatch, Inc., 136 F. Supp. 3d 503,

511 (S.D.N.Y. 2015). Defendants bring their motion to strike on this second basis. Defs. Mot. to Strike (“Defs. Mot.”) 9, ECF No. 23-1. B. Standards for Class Certification Because Defendants assert that it would be impossible to certify the alleged class, the Court briefly sets out the standards for certification.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Amchem Products, Inc. v. Windsor
521 U.S. 591 (Supreme Court, 1997)
Comcast Corp. v. Behrend
133 S. Ct. 1426 (Supreme Court, 2013)
Catholic Healthcare West v. US Foodservice Inc.
729 F.3d 108 (Second Circuit, 2013)
In Re Flag Telecom Holdings Securities Litigation
574 F.3d 29 (Second Circuit, 2009)
Sanders v. Tailored Chemical Corp.
570 F. Supp. 1543 (E.D. Pennsylvania, 1983)
Belfiore v. Procter & Gamble Co.
94 F. Supp. 3d 440 (E.D. New York, 2015)
Reynolds v. Lifewatch, Inc.
136 F. Supp. 3d 503 (S.D. New York, 2015)
Hidalgo v. Johnson & Johnson Consumer Companies
148 F. Supp. 3d 285 (S.D. New York, 2015)
Greene v. Gerber Products Co.
262 F. Supp. 3d 38 (E.D. New York, 2017)
Miles v. Merrill Lynch & Co.
471 F.3d 24 (Second Circuit, 2006)
Roach v. T.L. Cannon Corp.
778 F.3d 401 (Second Circuit, 2015)
Brecher v. Republic of Argentina
806 F.3d 22 (Second Circuit, 2015)
Kassman v. KPMG LLP
925 F. Supp. 2d 453 (S.D. New York, 2013)
Jones v. Allercare, Inc.
203 F.R.D. 290 (N.D. Ohio, 2001)
In re Rezulin Products Liability Litigation
210 F.R.D. 61 (S.D. New York, 2002)
Zehel-Miller v. Astrazenaca Pharmaceuticals, LP
223 F.R.D. 659 (M.D. Florida, 2004)
Sweet v. Pfizer
232 F.R.D. 360 (C.D. California, 2005)
In re Vioxx Products Liability Litigation
239 F.R.D. 450 (E.D. Louisiana, 2006)

Cite This Page — Counsel Stack

Bluebook (online)
Carr v. Johnson & Johnson Consumer Inc., Counsel Stack Legal Research, https://law.counselstack.com/opinion/carr-v-johnson-johnson-consumer-inc-nyed-2023.